Active ingredientOxeladin CitrateCat. No. P-O054-001CAS 52432-72-1Family · Pharmaceutical analytical standards
Oxeladin
A synthetic cough suppressant that acts on the cough centre in the medulla of the brainstem: its antitussive properties were described in a 1957 study, and it is used as drops, syrup and tablets. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Unlike codeine it has no link with opium or its derivatives: chemically it is an ester of 2-ethyl-2-phenylbutanoic acid.
Go to the active ingredient →Active ingredientOxeladin CitrateCat. No. P-O054-001CAS 52432-72-1
Pharmacopoeial impurityOxeladin EP Impurity CCat. No. P-O054-002
Pharmacopoeial impurityOxeladin Hydrogen Citrate EP Impurity ACat. No. P-O054-003CAS 140-82-9
ImpurityOxeladin N-OxideCat. No. P-O054-004CAS 1812854-79-7No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceOxeladin hydrogen citrate CRSEDQM code Y0000350Family OxeladinImpurityOxeladin impurity C CRSEDQM code Y0000404Family Oxeladin
ImpurityOxeladin impurity D CRSEDQM code Y0000390Family OxeladinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.